# China NMPA Drug Inspection - Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. - Dexamethasone sodium phosphate injection

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/sinopharm-group-rongsheng-pharmaceutical-co-ltd/ab92419e-19bb-49f0-876e-3cc305cf2640/
Source feed: China

> China NMPA drug inspection for Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. published March 20, 2020. Drug: Dexamethasone sodium phosphate injection. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Announcement from Gansu Provincial Drug Administration Regarding Sampling Inspection Information of Drugs Used for COVID-19 Prevention and Control
- Company Name: Sinopharm Group Rongsheng Pharmaceutical Co., Ltd.
- Publication Date: 2020-03-20
- Drug Name: Dexamethasone sodium phosphate injection
- Inspection Finding: qualified

Company: https://www.globalkeysolutions.net/companies/sinopharm-group-rongsheng-pharmaceutical-co-ltd/a6ab5514-40e8-4501-ae61-1775a7410d0f/